AS
Akash Sharma
About Akash Sharma
Data last updated:
Akash Sharma is a Director at Safecon Lifesciences Private Limited (since 2025), Director at Radhashok Pharmachem Private Limited (since 2025) and Director at Wellcon Animal Health Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Pharma. The 5 current companies with reported revenue have a combined latest revenue of ₹220 Cr; the largest is Safecon Lifesciences Private Limited at ₹87.00 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Apr 2025 | 2016 | ₹87.00 Cr (FY 2025) | Active | |
| Director | 26 May 2025 | 2016 | ₹68.78 Cr (FY 2025) | Active | |
| Director | 17 Apr 2025 | 2015 | ₹53.37 Cr (FY 2025) | Active | |
| Director | 09 May 2025 | 2005 | ₹7.27 Cr (FY 2025) | Active | |
| Director | 21 Apr 2025 | 2006 | ₹3.19 Cr (FY 2025) | Active |
Board colleagues of Akash Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anshul Agarwal | 06885646 | Safecon Lifesciences Private Limited , Radhashok Pharmachem Private Limited and 2 more | Director |
| Ashok Kumar Agarwal | 03169551 | Safecon Lifesciences Private Limited , Wellcon Animal Health Private Limited and 1 more | Director |
| Sankalp Mittal | 10422591 | Radhashok Pharmachem Private Limited | Director |
| Ankur Agarwal | 00548259 | Wellcon Animal Health Private Limited , Meek Pharma Private Limited and 1 more | Managing Director |
| Deepak Kumar Agarwal | 00917053 | Meek Pharma Private Limited | Director |
| Sachin Kumar Agrawal | 10730615 | Meek Pharma Private Limited | Director |
| Anjul Agarwal | 06897907 | Rachil Remedies Pvt Ltd | Director |
| Manoj Jain | 00717904 | Rachil Remedies Pvt Ltd | Director |
| Pran Nath Mehta | 02215443 | Rachil Remedies Pvt Ltd | Director |
| Suchita Mittal | 06898069 | Rachil Remedies Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Akash Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Akash Sharma
Akash Sharma currently holds 5 directorships: Safecon Lifesciences Private Limited (Director, since 02 Apr 2025, revenue ₹87.00 Cr (FY 2025)); Radhashok Pharmachem Private Limited (Director, since 26 May 2025, revenue ₹68.78 Cr (FY 2025)); Wellcon Animal Health Private Limited (Director, since 17 Apr 2025, revenue ₹53.37 Cr (FY 2025)); Meek Pharma Private Limited (Director, since 09 May 2025, revenue ₹7.27 Cr (FY 2025)); Rachil Remedies Pvt Ltd (Director, since 21 Apr 2025, revenue ₹3.19 Cr (FY 2025)).
Akash Sharma was first appointed on 02 Apr 2025 as Director at Safecon Lifesciences Private Limited.
The 5 current companies of Akash Sharma that report revenue have a combined latest revenue of ₹220 Cr: Safecon Lifesciences Private Limited ₹87.00 Cr (FY 2025); Radhashok Pharmachem Private Limited ₹68.78 Cr (FY 2025); Wellcon Animal Health Private Limited ₹53.37 Cr (FY 2025); Meek Pharma Private Limited ₹7.27 Cr (FY 2025); Rachil Remedies Pvt Ltd ₹3.19 Cr (FY 2025).
The current boards of Akash Sharma's companies include Anshul Agarwal (Safecon Lifesciences Private Limited), Ashok Kumar Agarwal (Safecon Lifesciences Private Limited), Sankalp Mittal (Radhashok Pharmachem Private Limited), Ankur Agarwal (Wellcon Animal Health Private Limited), Deepak Kumar Agarwal (Meek Pharma Private Limited), Sachin Kumar Agrawal (Meek Pharma Private Limited), among others.